Skip to content

Effect of nefopam for the prevention of withdrawal responses associated with rocuronium injection pain

Effect of nefopam for the prevention of withdrawal responses associated with rocuronium injection pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001959
Enrollment
76
Registered
2016-07-01
Start date
2016-05-10
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Chosun University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are scheduled to undergo elective surgery under general anesthesia with American Society of Anesthesiologists Physical Status classification I or II, between 20 and 65 years old.

Exclusion criteria

Exclusion criteria: A. Patients who do not sign a written informed consent B. Patients who taking the medication of opioids C. Patients with neuromuscular disease, renal function abnormality, hepatic function abnormality. D. Patients with convulsive disorder, mental disorder or above moderate cardiovascular diseases E. Patients who took anticonvulsants, antidepressant or other analgesics F. Patients with glaucoma and with or at risk of urinary retention G. Patients who can not access the intravenous fluid lines on the dorsum of hand H. Patients with an allergy to study drug I. pregnant , breastfeeding women, or women who Will be getting pregnant J. Aged under 20 or over 65 years

Design outcomes

Secondary

MeasureTime frame
Blood pressure;Respiratory rate;Side effect of nefopam;Heart rate

Primary

MeasureTime frame
Grade of withdrawal responses associated with rocuronium injection pain

Countries

Korea, Republic of

Contacts

Public ContactSANG HUN KIM

Chosun University Hospital

drshkim4187@yahoo.co.kr+82-62-230-3578

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026